Andrea Ellis SEC EDGAR Filings (CIK 0001877680)

SEC EDGAR filings, ownership reports, and insider transactions for Andrea Ellis.

Business address
C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA, 94304
Top holdings (ownership)
BBIO
Get insider transactions for this reporting owner
Andrea Ellis has filed 13 SEC EDGAR filings since 26 Aug 2021

Latest Filings

Recent SEC filings for Andrea Ellis including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 07 Aug 2025 05 Aug 2025 001-38959
144 Open 144 document View SEC filing for 144 05 Aug 2025
4 Open 4 document View SEC filing for 4 4 24 Jun 2025 20 Jun 2025 001-38959
4 Open 4 document View SEC filing for 4 4 16 Apr 2025 14 Apr 2025 001-38959
144 Open 144 document View SEC filing for 144 14 Apr 2025
4 Open 4 document View SEC filing for 4 4 03 Apr 2025 01 Apr 2025 001-38959
144 Open 144 document View SEC filing for 144 02 Apr 2025
4 Open 4 document View SEC filing for 4 4 25 Jun 2024 21 Jun 2024 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 23 Jun 2023 21 Jun 2023 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 24 Jun 2022 22 Jun 2022 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Mar 2022 15 Mar 2022 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Aug 2021 17 Aug 2021 001-38959
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 26 Aug 2021 17 Aug 2021 001-38959

About this filer

Andrea Ellis files with the SEC under CIK 0001877680. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages